Abstract
Heart failure (HF) is a growing health problem, at least in part due to the concurrent obesity epidemic plaguing developed countries. However, once a patient develops HF, an elevated BMI appears to confer a survival benefit – a phenomenon termed the “obesity paradox.” The exact explanation for this paradox has been difficult to ascertain. Numerous plausible mechanisms have been asserted, including the fact that obese patients tend to be younger and more symptomatic, leading them to seek medical attention earlier in the course of their HF. Obese patients may also have larger energy reserves that help to offset the catabolic changes seen with HF. Other hypotheses highlight the limitations of BMI as an obesity classifier. The purpose of this review is to examine the various theories for the obesity paradox in HF and discuss the implications for the clinical management of obese patients with HF.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart Disease and Stroke Statistics—2012 Update. Circulation. 2012;125(1):e2–220. doi:10.1161/CIR.0b013e31823ac046.
• Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachex Sarcopenia Muscle. 2012;3(1):1–4. doi:10.1007/s13539-012-0059-5. This is a review and opinion of the obesity paradox occuring in a number of chronic disease states and the implication of the obesity paradox for clinicians and researchers of health and disease.
Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13. doi:10.1056/NEJMoa020245.
Baena-Díez JM, Byram AO, Grau M, Gómez-Fernández C, Vidal-Solsona M, Ledesma-Ulloa G, et al. Obesity Is an Independent Risk Factor for Heart Failure: Zona Franca Cohort Study. Clin Cardiol. 2010;33(12):760–4. doi:10.1002/clc.20837.
Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80(6):736–40.
Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. Investigators ASACa. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153(1):74–81.
Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789–95.
Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, et al. Influence of etiology of heart failure on the obesity paradox. Am J Cardiol. 2009;104(8):1116–21. doi:10.1016/j.amjcard.2009.05.059.
Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61. doi:10.1001/archinte.165.1.55.
Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9(1):29–35. doi:10.1054/jcaf.2003.4.
• Nagarajan V, Cauthen CA, Starling RC, Tang WH. Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail. 2013;19(4):160–4. doi:10.1111/chf.12038. Nicely-done study from the Cleveland Clinic investigating the sometimes-reported “J-shape” survival curve of the obesity paradox. The findings support the idea that based on BMI, morbidly obese patients with HF have significantly higher risk of mortality than their obese counterparts.
Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13–22. doi:10.1016/j.ahj.2008.02.014.
Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol. 2004;43(8):1399–404. doi:10.1016/j.jacc.2003.10.062.
Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110(19):3081–7. doi:10.1161/01.CIR.0000147184.13872.0F.
Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321(4):249–79.
•• Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85(7):609–17. doi:10.4065/mcp.2010.0103. This is a comprehensive study highlighting the limitation of BMI and the strong correlation between elevated BMI and lean body mass in patients with HF. The higher lean mass with elevated BMI may be the reason for the factors associated with improved prognosis.
Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91(7):891–4.
Lee CG, Fujimoto WY, Brunzell JD, Kahn SE, McNeely MJ, Leonetti DL, et al. Intra-abdominal fat accumulation is greatest at younger ages in Japanese-American adults. Diabetes Res Clin Pract. 2010;89(1):58–64. doi:10.1016/j.diabres.2010.03.006.
Hairston KG, Scherzinger A, Foy C, Hanley AJ, McCorkle O, Haffner S, et al. Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes Care. 2009;32(8):1553–5. doi:10.2337/dc09-0336.
Fantin F, Di Francesco V, Fontana G, Zivelonghi A, Bissoli L, Zoico E, et al. Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol A Biol Sci Med Sci. 2007;62(12):1375–81.
Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Investig. 2013;36(7):537–43. doi:10.3275/8943.
•• Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail. 2011;17(5):374–80. doi:10.1016/j.cardfail.2011.01.009. One of the first studies to investigate the role of fat distribution using waist circumference in the context of the obesity paradox. Also, demonstrated the interaction of BMI and waist circumference.
Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol. 1996;28(5):1092–102. doi:10.1016/S0735-1097(96)00323-3.
• Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013;88(3):251–8. doi:10.1016/j.mayocp.2012.11.020. This is an analysis of a very large cohort of patients with HF undergoing cardiopulmonary exercise testing. These results suggest that cardiorespiratory fitness may be more important than BMI in the context of the obesity paradox. This study adds to the idea that there are limits to the obesity paradox.
Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000;36(7):2126–31.
Green DJ, Watts K, Maiorana AJ, Kuipers T, Ackland T, O'Driscoll JG. A comparison of methods for the calculation of peak oxygen uptake in patients with heart failure. J Cardpulm Rehabil. 2002;22(2):85–8.
Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Shaw LJ, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 1996;27(2):345–52.
Wasserman K. Principles of exercise testing and interpretation : including pathophysiology and clinical applications. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, et al. Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure. Circ Heart Fail. 2009;2(2):113–20. doi:10.1161/CIRCHEARTFAILURE.108.834168.
Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol. 1997;30(7):1758–64.
Anker SD, Swan JW, Volterrani M, Chua TP, Clark AL, Poole-Wilson PA, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997;18(2):259–69.
Allison DB, Zannolli R, Faith MS, Heo M, Pietrobelli A, VanItallie TB, et al. Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999;23(6):603–11.
Myers J, Lata K, Chowdhury S, McAuley P, Jain N, Froelicher V. The obesity paradox and weight loss. Am J Med. 2011;124(10):924–30. doi:10.1016/j.amjmed.2011.04.018.
Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med. 2009;122(12):1106–14. doi:10.1016/j.amjmed.2009.06.006.
Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–32. doi:10.1016/j.jacc.2008.12.068.
Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077–83. doi:10.1016/S0140-6736(03)12892-9.
Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29(21):2641–50. doi:10.1093/eurheartj/ehn420.
Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transplant. 2006;25(9):1024–42. doi:10.1016/j.healun.2006.06.008.
• Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16(6):e1–194. doi:10.1016/j.cardfail.2010.04.004. These are the current guidelines for the care and treatment of patients with HF in the US.
•• Lainscak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2011;13(2):115–26. doi:10.1093/eurjhf/hfq219. This is the most current recommendation from the Heart Failure Association of the European Society of Cardiology concerning the self-care management of HF. These recommendations are well-supported and provide clear recommendations in a number of important areas related to patient self-care.
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure: HF-ACTION Randomized Controlled Trial. JAMA. 2009;301(14):1439–50. doi:10.1001/jama.2009.454.
Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Thomas RJ, Squires RW, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008;15(3):336–40. doi:10.1097/HJR.0b013e3282f48348.
States U. Department of Health and Human Services. 2008 physical activity guidelines for Americans : be active, healthy, and happy! ODPHP publication, vol no U0036. Washington, DC: U.S. Dept. of Health and Human Services; 2008.
Keteyian SJ, Piña IL, Hibner BA, Fleg JL. Clinical role of exercise training in the management of patients with chronic heart failure. J Cardpulm Rehabil Prev. 2010;30(2):67–76. doi:10.1097/HCR.0b013e3181d0c1c1.
Compliance with Ethics Guidelines
Conflict of Interest
Paul J. Chase, Paul G. Davis, and Daniel R. Bensimhon declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chase, P.J., Davis, P.G. & Bensimhon, D.R. The Obesity Paradox in Chronic Heart Failure: What Does It Mean?. Curr Heart Fail Rep 11, 111–117 (2014). https://doi.org/10.1007/s11897-013-0184-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11897-013-0184-2